Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Can platelet Iymphocyte ratio and neutrophil to lymphocyte ratio be used as prognostic predictors for hepatocellular carcinoma?

Ebru Hatice Ayvazoglu Soy, Huseyin Onur Aydin, Gokhan Moray.




Abstract
Cited by 1 Articles

Aim: To investigate the predictive value of platelet to lymphocyte and neutrophil to lymphocyte ratios for hepatocellular carcinoma outcomes
Material and Methods: 37 hepatocellular carcinoma patients were retrospectively collected. All of the hepatocellular carcinoma patients were treated with conventional methods; transarterial chemoembolization, radiofrequency ablation or both. The patient and tumor characteristics, platelet to lymphocyte ratio and neutrophil to lymphocyte ratio were recorded. The association between platelet to lymphocyte ratio and neutrophil to lymphocyte ratio and tumor free survival rates, recurence rates, need of repeated conventional therapy were analyzed.
Results: The mean MELD (model for end stage liver disease) score of 37 hepatocellular carcinoma patients was 10.75±4.484 (mean age 59.59±17.23 years). High platelet to lymphocyte ratio and neutrophil to lymphocyte ratio were found to be associated with hepatocellular carcinoma recurrence (p0.05). Platelet to lymphocyte ratio and neutrophil to lymphocyte ratios were significantly high in patients who had repated transarterial chemoembolisation, radiofrequency ablation or both (p

Key words: Hepatocellular Carcinoma; Platelet To Lymphocyte Ratio; Neutrophil To Lymphocyte Ratio; Treatment Response; Recurrence.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.